WEBINAR DATE:.Wednesday, May 17 – 6:00 PM PST

PRESENTER: Caroline MacCallum, MD, FRCPC (Internal Medicine), BSc Pharm

PRESENTATION OUTLINE

Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult population. Evidence suggests a potential role of cannabis as an adjunctive therapy with or without opioids to optimize pain control. This program will cover the key components a clinician needs to understand the potential role of medical cannabis as an adjunct treatment to opioids in patients with chronic pain, including: cannabis-opioid synergy, risks, and treatment approaches.

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

1. Understand the role of cannabinoids in pain modulation and cannabis-opioid mutual potentiation
2. Evaluate the current research literature pertaining to the safety and efficacy of cannabis and opioids for pain
3. Know the proposed steps for cannabis adjunct initiation trial with opioid therapy

PROGRAM AGENDA

6:00 – Introduction
6:05 – Current Opioid Epidemic
6:10 – Cannabis and Opioid Safety
6:15 – Why Consider Cannabis for Pain?
6:30 – Evidence for Cannabis and Opioids
6:50 – Questions and Discussion
7:00 – Practical Considerations
7:15 – Opioid Reduction Using Cannabis
7:25 – Case Walk Through
7:30 – Interactive Cases
8:00 – Adjournment

This 1-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada for up to 2 Mainpro+ Credits

REGISTER – MAY 17 (PST)

Participation is restricted to physicians, pharmacists, and other licensed health care providers